Answer
Injection site reactions were the most frequently reported adverse reactions to marstacimab in clinical studies, occurring in 11.2% of patients.
Sources for this answer
- Hympavzi 150 mg solution for injection in pre-filled penPfizer Limited · emc · SmPC §4.8 Undesirable effects · Version 4Document updated
Sources checked